Novartis' Sandoz goes digital from back office to 'not just apps,' therapeutics

"Pharma's digital revolution is well underway, and Sandoz is placing some big bets that tech can transform the company—and everything it does.

The Novartis generics business is taking on digital and data technologies from discovery and development all the way to commercialization, believing the approach can open up healthcare access and improve patient outcomes.

Leading the digital transformation push in North America is Carol Lynch, president of Sandoz U.S. and head of North America, and Mike Fraser, VP of strategy, innovation and analytics. The two talked to FiercePharma recently about Sandoz and Novartis’ strategy, programs and mission in digital technology.

“We're looking across the whole value chain to make sure we’re embracing digital and technology wherever we can. So that means from the way that we innovate, to the way that we sell and the way that we operate and do day-to-day business,” Lynch said. “That spans a whole range of activities from how do you use AI and automation all the way through to prescription digital therapies.”..." Lire la suite